Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Clinical and demographic characteristics of the participants. حسب María Benito-de-Pedro (22057468)

الموضوعات:

Respiratory clinical characteristics of smokers and non-smokers. حسب Prasanna Herath (20714794)

الموضوعات:

Centrifuged FMT products consistently exhibit the lowest median log₁₀ drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log₁₀ drop and had a statistically significant loss of bacterial viability across both storage conditions.... حسب Nina K. Randolph (21030732)

"…In contrast, unprocessed feces exhibited the greatest median log₁₀ drop and had a statistically significant loss of bacterial viability across both storage conditions. …"

ROBINS-I assessments. حسب Martha R. Smith (20410184)

الموضوعات:

S8 File - حسب Martha R. Smith (20410184)

الموضوعات:

Study populations of included studies. حسب Martha R. Smith (20410184)

الموضوعات:

Future research directions. حسب Martha R. Smith (20410184)

الموضوعات:

PRISMA flow diagram. حسب Martha R. Smith (20410184)

الموضوعات:

Exercise protocols and results of included studies. حسب Martha R. Smith (20410184)

الموضوعات:

Participant characteristics in studies of children with biopsy-proven NAFLD. حسب Martha R. Smith (20410184)

الموضوعات:

S9 File - حسب Martha R. Smith (20410184)

الموضوعات:

RoB 2 assessments. حسب Martha R. Smith (20410184)

الموضوعات: